page contents

Johnson & Johnson: Another Day, Another Bullish Analyst

Yet another analyst has declared that shares of Johnson & Jonson (JNJ) can still climb higher even after posting 19% gains since the start of the year.

It was back in April when my colleague Ben Levisohn said that the selloff in J&J shares that followed the healthcare conglomerate’s first quarter revenue miss was a buying opportunity,…
Stocks to Watch

PLEASE CLICK ON PUBLISHER ABOVE TO READ COMPLETE ARTICLE

Leave a Reply

Your email address will not be published. Required fields are marked *

*